Jane Street
WHWK

Jane Street’s Whitehawk Therapeutics WHWK Stock Holding History

Jane Street’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$69K – 13612
2026
Q1 		$69K Buy
+20,000
New +$62.6K ﹤0.01% 10829

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's WHWK Position: Q2 2026 in Review

Jane Street sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 151,110 shares — an estimated $521K sold.

Jane Street first reported a position in WHWK in Q3 2018 and held it in 17 quarters. The position peaked at $683K in Q1 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Jane Street reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 151,110 Whitehawk Therapeutics shares in Q2 2026, an estimated $521K.
  • Jane Street first reported a position in Whitehawk Therapeutics in Q3 2018 and held it in 17 quarters.
  • Jane Street's Whitehawk Therapeutics position peaked at $683K in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.